| Symbol | QBIO |
|---|---|
| Name | Q BIOMED INC. |
| Sector | UNDEFINED |
| Region | North America |
| Industry | - |
| Address | 10017 United States NY c/o Ortoli Rosenstadt LLP 366 Madison Avenue |
| Telephone | (212) 588-0022 |
| Fax | — |
| — | |
| Website | http://www.qbiomed.com |
| Incorporation | US |
| Incorporated On | 2013 |
| Employees | — |
| Fiscal Year | 11/30 |
| Public Since | — |
| Exchanges | OTC |
| Auditor | Marcum LLP; |
| Audit Status | UNAUDITED |
| Reporting Status | U.S. Reporting: SEC Reporting |
| CIK | 0001596062 |
| Description | Q BioMed Inc. Q`` is a biomedical acceleration and development company focused on acquiring companies and biomedical assets in clinical stage or and near revenue development. Q is dedicated to providing these target companies strategic resources, developmental support, and expansion capital to ensure they meet their developmental potential enabling them to provide products to patients in need. Additional info from OTC: |
New Form SC 13G/A - Q BioMed Inc. Filed: 2024-11-04 AccNo: 0001104659-24-113973 Size: 121 KB
Read moreExpert Market symbol attribute type Security_Name was changed. Previous value: -. New value: Q BIOMED INC..
Read moreOTCQX U.S. Premier symbol attribute type Security_Name was changed. Previous value: CONSUMERS BANCORP INC. New value: Q BIOMED INC..
Read more